Testing an injection therapy for stubborn ringworm infections
Part of Infections, Skin clinical trials.
This study tests a new type of injection treatment for stubborn ringworm (tinea) infections that haven't improved with standard pills or creams. It aims to see if this immunotherapy works better for hard-to-treat cases, especially when the fungus might be resistant to usual medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 10 and 60 years old.
- You have ringworm that did not get better after at least two different prescription antifungal treatments in the last 3 months.
- The infection is spreading fast, covers large areas, or keeps coming back. (Or someone else in your home, especially a woman or child, also has ringworm.)
- If you are a woman who could become pregnant, you must agree to use reliable birth control during the study.
- You are not pregnant or breastfeeding, and you do not have a condition that weakens your immune system (like uncontrolled diabetes or HIV).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two oral medications, fluconazole and itraconazole, to see which works better for treating ringworm that hasn't cleared up with topical creams. If you've had ringworm for at least 6 months despite using antifungal creams, this study may help find a more effective treatment.
This study compares two treatments for a common fungal skin infection called tinea (ringworm). One group gets itraconazole alone, the other gets itraconazole plus isotretinoin. The goal is to see which approach clears the infection faster, safer, and with a higher cure rate.
This study is looking at hard-to-treat fungal skin infections to see what they look like under a microscope and under special skin imaging (dermoscopy). It may help find better ways to treat these stubborn infections.
This study tests if ultraviolet B (UVB) light therapy can help treat ringworm infections that have not cleared with standard antifungal pills. It may be an option if you have had multiple ringworm infections or one that keeps coming back.
This study tests a medicine called voriconazole (an oral antifungal) for people whose ringworm infections on the groin or trunk have not responded to standard treatments. If you qualify, you would take this medicine to see if it can clear the infection.
This study tests a new antifungal drug (EL219) compared to two standard treatments (liposomal amphotericin B or voriconazole) for people with weakened immune systems who have a suspected or confirmed mold infection. The goal is to see if the new drug works as well or better at treating the infection.
Hear when a new Tinea Corporis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.